drugset / Trial / NCT03963479
Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients
RandomizedParallel-groupTriple-blindSupportive care
Summary
To determine whether Vitamin B6 and Magnesium improve neurobehavioral status in terms of General observation, Cognitive working, Socialization, Communication and Sensory Dysfunction in patient with Autism Spectrum Disorder.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 50 mg | — |
| Subject | Magnesium Sulfate | Other / unclassified | 100 mg | — |
| Subject | Magnesium Sulfate | Other / unclassified | 200 mg | — |
| Subject | Pyridoxine | Unknown | 25 mg | — |
| Subject | Pyridoxine | Unknown | 50 mg | — |
| Subject | Pyridoxine | Unknown | 100 mg | — |